6 news items
Coherus Management to Present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA
CHRS
23 May 24
will be accessible via Webcast through a link on the Investor Events and Presentations section of the Coherus website
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
CHRS
9 May 24
When: Thursday, May 9, 2024, starting at 5:00 p.m. Eastern Daylight Time To access the conference call: Dial
Coherus to Report First Quarter 2024 Financial Results on May 9, 2024
CHRS
1 May 24
, starting at 5:00 p.m. Eastern Daylight Time To access the conference call:Dial: (800) 715-9871 (toll-free USA and Canada); (646) 307-1963
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
CHRS
13 Mar 24
To access the conference call, please register through the following link to receive dial-in information and a personal PIN to access the live
Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
CHRS
5 Mar 24
When: Wednesday, March 13, 2024, starting at 5:00 p.m. Eastern Time To access the conference call, please pre-register through
n9tx514q6iomceibhllh 76ta9j6dk4jh2rpyjjhubtj5r0lkc0
CHRS
4 Mar 24
included Coherus' CIMERLI biologics license application, ophthalmology sales and select field reimbursement teams, and access to proprietary
- Prev
- 1
- Next